1. Long-term clinical and positron emission tomography outcome of fetal striatal transplantation in Huntington's disease.
- Author
-
Reuter I, Tai YF, Pavese N, Chaudhuri KR, Mason S, Polkey CE, Clough C, Brooks DJ, Barker RA, and Piccini P
- Subjects
- Adrenergic Uptake Inhibitors therapeutic use, Adult, Brain Edema diagnostic imaging, Carbon Radioisotopes, Case-Control Studies, Caudate Nucleus diagnostic imaging, Combined Modality Therapy, Cyclosporine adverse effects, Cyclosporine therapeutic use, Dopamine Antagonists, Female, Follow-Up Studies, Humans, Immunosuppressive Agents adverse effects, Immunosuppressive Agents therapeutic use, Lymphocytosis diagnostic imaging, Male, Middle Aged, Morpholines therapeutic use, Neurologic Examination, Neuropsychological Tests, Putamen diagnostic imaging, Raclopride, Reboxetine, Stereotaxic Techniques, Tissue Survival physiology, Brain Tissue Transplantation, Caudate Nucleus surgery, Corpus Striatum embryology, Corpus Striatum transplantation, Fetal Tissue Transplantation, Huntington Disease diagnostic imaging, Huntington Disease surgery, Positron-Emission Tomography, Postoperative Complications diagnostic imaging, Putamen surgery
- Abstract
Two patients with moderate Huntington's disease (HD) received bilateral fetal striatal allografts. One patient demonstrated, for the first time, increased striatal D2 receptor binding, evident with 11C-raclopride positron emission tomography, and prolonged clinical improvement over 5 years, suggesting long term survival and efficacy of the graft. The other patient did not improve clinically or radiologically. Our results indicate that striatal transplantation in HD may be beneficial but further studies are needed to confirm this.
- Published
- 2008
- Full Text
- View/download PDF